ORC6 and non-small cell lung carcinoma: In primary NSCLC cells, silencing or KO of ORC6 led to reduced expression of Cyclin A2, Cyclin B1, and Cyclin D1, whereas their levels increased in ORC6-overexpressing NSCLC cells.